Medical Update in AML: New Treatments and Blood Stem Cell Transplantation

Last Modified: August 26, 2004

Share article


Conference Dates: September 22, 2004
Conference Location: Telephone Conference


Sponsoring Group: National Marrow Donor Program, CancerCare and The Leukemia & Lymphoma Society

Conference Web Page URL: www.marrow.org/NEWS/EVENTS/aml_workshop.html

Topics Covered: An overview of acute myelogenous leukemia (AML), by Dr. Selina Luger An overview of AML treatment options, including marrow and blood stem cell transplantation, by Dr. Douglas Rizzo.

Conference Objectives: Provide an overview for patients on treatment options for AML, including marrow and blood cell transplantation

Who Should Attend: Patients

Conference Fees: Free

Continuing Education: No


News
Also, double unrelated cord blood transplant tied to better outcomes in leukemia patients

Dec 8, 2010 - Individuals who donate peripheral blood stem cells or bone marrow do not appear to be at an overall increased risk of cancer, according to research being presented at the annual meeting of the American Society of Hematology, held from Dec. 4 to 7 in Orlando, Fla. According to another study, acute myeloid or lymphoblastic leukemia patients who receive double unrelated cord blood transplants may experience better overall outcomes than those who receive single cord blood transplants. Other studies being presented address stem cell transplant procedures in treating various hematologic malignancies and highlight zoledronic acid's ability to improve survival in multiple myeloma patients.



I Wish You Knew

How cancer patients have changed my life

View More



Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.




OncoLink OncoPilot

Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!

Learn More